{
  "ptid_time": "128_S_0863_2006-09-25",
  "img_path": "/data/qiuhui/data/adni/images/128_S_0863/2006-09-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 75,080 mm³, 94.9% above the reference mean. With a Z-score of 2.27 (98.9th percentile), this represents significant enlargement; hippocampal volume measures 6,125 mm³, 19.0% below the reference mean. With a Z-score of -1.85 (3.2th percentile), this represents moderate atrophy; whole brain volume measures 1,004,690 mm³, 6.9% below the reference mean. With a Z-score of -0.90 (18.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,124 mm³, 23.8% below the reference mean. With a Z-score of -1.62 (5.3th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,697 mm³, 11.4% below the reference mean. With a Z-score of -0.97 (16.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,896 mm³, 11.4% below the reference mean. With a Z-score of -1.03 (15.2th percentile), this represents mild atrophy. ",
  "text_data": "Age is 79.1 years. Gender is Male. Education: 15 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Endocrine-Metabolic; Smoking; Major Surgical Procedures. MMSE: 26.0. Logical Memory: 9.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (94.9% above mean) and moderate hippocampal atrophy (19.0% below mean), both strong indicators of neurodegeneration. The MMSE score of 26 is borderline, but structural changes (especially hippocampal and entorhinal atrophy) suggest cognitive impairment beyond normal aging.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (High structural evidence but MMSE is near-normal; APOE4-negative status reduces Alzheimer's likelihood but doesn't rule out other causes of MCI).  \n\n*(Note: A full clinical evaluation, including neuropsychological testing and CSF/amyloid biomarkers, would strengthen confidence.)*",
  "timestamp": "2025-07-26T13:50:11.573950"
}